Jpmorgan Chase & CO Akoya Biosciences, Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Akoya Biosciences, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 12,220 shares of AKYA stock, worth $26,395. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,220

Previous 11,870 2.95%

Holding current value

$26,395

Previous $27,000 22.22%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$1.96 - $2.94 $686 - $1,029	350 Added 2.95%	12,220 $33,000
Q2 2024 Aug 12, 2024	SELL	$1.94 - $4.56 $5,484 - $12,891	-2,827 Reduced 19.24%	11,870 $27,000
Q1 2024 May 10, 2024	SELL	$4.33 - $6.06 $51 - $72	-12 Reduced 0.08%	14,697 $68,000
Q3 2023 Nov 14, 2023	BUY	$4.24 - $7.44 $848 - $1,488	200 Added 1.38%	14,709 $68,000
Q2 2023 Aug 11, 2023	BUY	$5.28 - $8.35 $12,751 - $20,165	2,415 Added 19.97%	14,509 $107,000
Q1 2023 May 18, 2023	BUY	$7.6 - $12.68 $91,815 - $153,187	12,081 Added 92930.77%	12,094 $98,000
Q1 2023 May 11, 2023	SELL	$7.6 - $12.68 $67,845 - $113,194	-8,927 Reduced 99.85%	13 $0
Q4 2022 Feb 13, 2023	BUY	$8.6 - $14.1 $2,777 - $4,554	323 Added 3.75%	8,940 $85,000
Q3 2022 Nov 14, 2022	BUY	$10.63 - $15.76 $1,977 - $2,931	186 Added 2.21%	8,617 $101,000
Q2 2022 Aug 11, 2022	BUY	$8.38 - $12.85 $17,916 - $27,473	2,138 Added 33.97%	8,431 $108,000
Q1 2022 May 11, 2022	BUY	$9.84 - $14.97 $4,014 - $6,107	408 Added 6.93%	6,293 $69,000
Q4 2021 Feb 10, 2022	BUY	$11.37 - $15.31 $33,575 - $45,210	2,953 Added 100.72%	5,885 $90,000
Q3 2021 Nov 12, 2021	BUY	$13.04 - $21.0 $38,233 - $61,572	2,932 New	2,932 $41,000

Others Institutions Holding AKYA

# of Institutions

Shares Held

11.9M

Call Options Held

24.1K

Put Options Held

View Full List

About Akoya Biosciences, Inc.

Ticker AKYA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 37,892,300
Market Cap $81.8M
Description
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope...

More about AKYA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Akoya Biosciences, Inc. Transaction History